LLY
1,014.98
-0.96%↓
JNJ
240.9
+1.12%↑
ABBV
220.69
-0.72%↓
NVS
159.71
+1.01%↑
MRK
119.32
+1.9%↑
LLY
1,014.98
-0.96%↓
JNJ
240.9
+1.12%↑
ABBV
220.69
-0.72%↓
NVS
159.71
+1.01%↑
MRK
119.32
+1.9%↑
LLY
1,014.98
-0.96%↓
JNJ
240.9
+1.12%↑
ABBV
220.69
-0.72%↓
NVS
159.71
+1.01%↑
MRK
119.32
+1.9%↑
LLY
1,014.98
-0.96%↓
JNJ
240.9
+1.12%↑
ABBV
220.69
-0.72%↓
NVS
159.71
+1.01%↑
MRK
119.32
+1.9%↑
LLY
1,014.98
-0.96%↓
JNJ
240.9
+1.12%↑
ABBV
220.69
-0.72%↓
NVS
159.71
+1.01%↑
MRK
119.32
+1.9%↑
24h
Curent
Minim
Maxim
Recomandări | Cumpărare |
|---|---|
Prognoză pe 12 luni | +11.93% upside |
By Acuity
50%
50%
149 / 352 Clasament în Healthcare
Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.
24 oct. 2025, 13:04 UTC
Eli Lilly Agrees to Acquire Adverum Biotechnologies
DJ
Citește
9 dec. 2025, 13:32 UTC
Eli Lilly: Parties Expect to Consummate the Acquisition on Dec 9 >LLY
DJ
Citește
9 dec. 2025, 13:32 UTC
Lilly and Purchaser Accepted for Payment, and Will Promptly Pay, for All Shrs
DJ
Citește
9 dec. 2025, 13:29 UTC
Lilly and Adverum Announce Expiration and Completion of Adverum Tender Offer and Acquisition
DJ
Citește
24 oct. 2025, 12:34 UTC
Eli Lilly Says Transaction Is Expected to Close in the 4Q >LLY
DJ
Citește
24 oct. 2025, 12:34 UTC
Eli Lilly: Offer Also Includes 1 Non-Transferrable Contingent Value Right Entitling Holder to Receive Up to an Additional $8.91 Per CVR in Cash Upon the Achievement of 2 Milestones, for Total Potential Consideration of Up to $12.47/Shr >LLY
DJ
Citește
24 oct. 2025, 12:33 UTC
Eli Lilly to Launch Tender Offer to Acquire All Outstanding Shares of Adverum for $3.56/Shr >LLY
DJ
Citește
24 oct. 2025, 12:30 UTC
Lilly To Acquire Adverum Biotechnologies >LLY ADVM
DJ
Citește
Modificare preț
By TipRanks
Prognoză pe 12 luni
Medie 4.88 USD 11.93%
Maxim 5.5 USD
Minim 4 USD
În baza a 5 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruAdverum Biotechnologies Inc - Dist în ultimele 3 luni.
By TipRanks
Cumpărare
5 ratings
2
Cumpărare
3
Păstrare
0
Vânzare
Ținând cont de 5 analiști care au acordat evaluări ale acțiunilor Adverum Biotechnologies Inc - Dist în ultimele 3 luni.
By Acuity
Sentimentul știrilor
Neutral
Volatilitate
Sub medie
Volumul știrilor (RCV)
Sub medie
$